94 results
Page 3 of 5
8-K
EX-10.1
a4kj2re
7 Aug 17
AntriaBio and ActiveSite Pharmaceuticals Announce License and Development Agreement for Plasma Kallikrein Inhibitors
12:00am
8-K
EX-10.1
6k5fe
6 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.7
z8bdc1zxgvpq74cuh3q
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.6
rhzwx2ryjl x17nj8d
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
lcf e81rl
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
oyl1mjzj6
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
kdf2mrh
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
wnouq8y9vr6
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
1foomn dagh5
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
8p3495o9
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
bfeb2r5j17wwhd1kvu8
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
83ngt1e64jxj3pkh4fy
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.4
8ywc7hsyw ap
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.1
mljyabunp 704
2 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
hjxg38kq cow6
6 Apr 15
Entry into a Material Definitive Agreement
12:00am